4Ps Screening Tool for Drug and Alcohol Use (PDF - 10.2 KB KB)
This screening device is often used as a way to begin discussion about drug and alcohol use. Any woman who answers yes to one or more questions should be referred for further assessment.
This collection of tools and resources is for providers, staff, and patients who offer or use services to address substance use, and other interested stakeholders. This collection was originally established following an environmental scan on implementing medication-assisted treatment (MAT) for opioid use disorder (OUD) in rural primary care. (See PDFs of Volume 1 (PDF - 609 KB) and Volume 2 (PDF - 1.3 MB) of that scan). Items have been continuously added to this collection since then, and the collection has expanded to cover substance use more broadly, rather than just MAT for OUD.
This screening device is often used as a way to begin discussion about drug and alcohol use. Any woman who answers yes to one or more questions should be referred for further assessment.
Details evidence-based clinical practice guidelines for use of chronic opioid therapy in adults with chronic noncancer pain.
Predicts aberrant medication-related behaviors among persons with chronic pain and complements current risk assessment practices to improve a clinician's ability to assess a patient's risk for opioid misuse.
Uses a 17-item self-assessment to identify patients with chronic pain taking opioids who have indicators of current aberrant drug-related behaviors.
Assesses the intensity of pain and the level of interference in normal daily life using a three-item scale.
Provides recommendations on how to properly use and prescribe opioid medication for both acute and chronic pain.
Helps clinicians better identify the presence of opioid abuse or dependence in patients with chronic pain.
Helps patients keep track of their function, pain, sleep, and alcohol/drug use. Allows providers to then use the chart to properly adjust the patient's medications to obtain optimal benefit and to minimize risk to health and safety.
Describes development and validation of a low-literacy, English-language opioid contract.